Results of Polish Adult Leukemia Study Group (PALG) project assessing TP53 mutations with next-generation sequencing technology in relapsed and refractory chronic lymphocytic leukemia patients — an 18-month update

Abstract

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

TP53 mutations in chronic lymphocytic leukemia

“…Pepek et al [6], in this issue of "Acta Haematologica Polonica", report the results of a study examining the use of NGS in identifying TP53 mutations in relapsed and refractory chronic lymphocytic leukemia (CLL) patients in Poland. The study was initiated by the Polish Adult Leukemia Group (PALG) as an observational study and educational project aimed primarily at providing Polish hematologists with the possibility of testing TP53 mutations by NGS.…”